Cargando…

Qualitative Evidence Synthesis (QES) for Guidelines: Paper 1 – Using qualitative evidence synthesis to inform guideline scope and develop qualitative findings statements

BACKGROUND: WHO has recognised the need to ensure that guideline processes are transparent and evidence based, and that the resulting recommendations are relevant and applicable. Along with decision-making criteria that require findings from effectiveness reviews, WHO is increasingly using evidence...

Descripción completa

Detalles Bibliográficos
Autores principales: Downe, Soo, Finlayson, Kenneth W., Lawrie, Theresa A., Lewin, Simon A., Glenton, Claire, Rosenbaum, Sarah, Barreix, María, Tunçalp, Özge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686511/
https://www.ncbi.nlm.nih.gov/pubmed/31391057
http://dx.doi.org/10.1186/s12961-019-0467-5
_version_ 1783442583391830016
author Downe, Soo
Finlayson, Kenneth W.
Lawrie, Theresa A.
Lewin, Simon A.
Glenton, Claire
Rosenbaum, Sarah
Barreix, María
Tunçalp, Özge
author_facet Downe, Soo
Finlayson, Kenneth W.
Lawrie, Theresa A.
Lewin, Simon A.
Glenton, Claire
Rosenbaum, Sarah
Barreix, María
Tunçalp, Özge
author_sort Downe, Soo
collection PubMed
description BACKGROUND: WHO has recognised the need to ensure that guideline processes are transparent and evidence based, and that the resulting recommendations are relevant and applicable. Along with decision-making criteria that require findings from effectiveness reviews, WHO is increasingly using evidence derived from qualitative evidence syntheses (QES) to inform the values, acceptability, equity and feasibility implications of its recommendations. This is the first in a series of three papers examining the use of QES in developing clinical and health systems guidelines. METHODS: WHO convened a group of methodologists involved in developing recent (2010–2018) guidelines that were informed by QES. Using a pragmatic and iterative approach that included feedback from WHO staff and other stakeholders, the group reflected on, discussed and identified key methods and research implications from designing QES and using the resulting findings in guideline development. Our aim in this paper is to (1) describe and discuss how the findings of QES can inform the scope of a guideline and (2) develop findings for key guideline decision-making criteria. RESULTS: QES resulted in the addition of new outcomes that are directly relevant to service users, a stronger evidence base for decisions about how much effective interventions and related outcomes are valued by stakeholders in a range of contexts, and a more complete database of summary evidence for guideline panels to consider, linked to decisions about values, acceptability, feasibility and equity. CONCLUSIONS: Rigorously conducted QES can be a powerful means of improving the relevance of guidelines, and of ensuring that the concerns of stakeholders, at all levels of the healthcare system and from a wide range of settings, are taken into account at all stages of the process. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12961-019-0467-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6686511
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66865112019-08-12 Qualitative Evidence Synthesis (QES) for Guidelines: Paper 1 – Using qualitative evidence synthesis to inform guideline scope and develop qualitative findings statements Downe, Soo Finlayson, Kenneth W. Lawrie, Theresa A. Lewin, Simon A. Glenton, Claire Rosenbaum, Sarah Barreix, María Tunçalp, Özge Health Res Policy Syst Research BACKGROUND: WHO has recognised the need to ensure that guideline processes are transparent and evidence based, and that the resulting recommendations are relevant and applicable. Along with decision-making criteria that require findings from effectiveness reviews, WHO is increasingly using evidence derived from qualitative evidence syntheses (QES) to inform the values, acceptability, equity and feasibility implications of its recommendations. This is the first in a series of three papers examining the use of QES in developing clinical and health systems guidelines. METHODS: WHO convened a group of methodologists involved in developing recent (2010–2018) guidelines that were informed by QES. Using a pragmatic and iterative approach that included feedback from WHO staff and other stakeholders, the group reflected on, discussed and identified key methods and research implications from designing QES and using the resulting findings in guideline development. Our aim in this paper is to (1) describe and discuss how the findings of QES can inform the scope of a guideline and (2) develop findings for key guideline decision-making criteria. RESULTS: QES resulted in the addition of new outcomes that are directly relevant to service users, a stronger evidence base for decisions about how much effective interventions and related outcomes are valued by stakeholders in a range of contexts, and a more complete database of summary evidence for guideline panels to consider, linked to decisions about values, acceptability, feasibility and equity. CONCLUSIONS: Rigorously conducted QES can be a powerful means of improving the relevance of guidelines, and of ensuring that the concerns of stakeholders, at all levels of the healthcare system and from a wide range of settings, are taken into account at all stages of the process. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12961-019-0467-5) contains supplementary material, which is available to authorized users. BioMed Central 2019-08-08 /pmc/articles/PMC6686511/ /pubmed/31391057 http://dx.doi.org/10.1186/s12961-019-0467-5 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Downe, Soo
Finlayson, Kenneth W.
Lawrie, Theresa A.
Lewin, Simon A.
Glenton, Claire
Rosenbaum, Sarah
Barreix, María
Tunçalp, Özge
Qualitative Evidence Synthesis (QES) for Guidelines: Paper 1 – Using qualitative evidence synthesis to inform guideline scope and develop qualitative findings statements
title Qualitative Evidence Synthesis (QES) for Guidelines: Paper 1 – Using qualitative evidence synthesis to inform guideline scope and develop qualitative findings statements
title_full Qualitative Evidence Synthesis (QES) for Guidelines: Paper 1 – Using qualitative evidence synthesis to inform guideline scope and develop qualitative findings statements
title_fullStr Qualitative Evidence Synthesis (QES) for Guidelines: Paper 1 – Using qualitative evidence synthesis to inform guideline scope and develop qualitative findings statements
title_full_unstemmed Qualitative Evidence Synthesis (QES) for Guidelines: Paper 1 – Using qualitative evidence synthesis to inform guideline scope and develop qualitative findings statements
title_short Qualitative Evidence Synthesis (QES) for Guidelines: Paper 1 – Using qualitative evidence synthesis to inform guideline scope and develop qualitative findings statements
title_sort qualitative evidence synthesis (qes) for guidelines: paper 1 – using qualitative evidence synthesis to inform guideline scope and develop qualitative findings statements
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686511/
https://www.ncbi.nlm.nih.gov/pubmed/31391057
http://dx.doi.org/10.1186/s12961-019-0467-5
work_keys_str_mv AT downesoo qualitativeevidencesynthesisqesforguidelinespaper1usingqualitativeevidencesynthesistoinformguidelinescopeanddevelopqualitativefindingsstatements
AT finlaysonkennethw qualitativeevidencesynthesisqesforguidelinespaper1usingqualitativeevidencesynthesistoinformguidelinescopeanddevelopqualitativefindingsstatements
AT lawrietheresaa qualitativeevidencesynthesisqesforguidelinespaper1usingqualitativeevidencesynthesistoinformguidelinescopeanddevelopqualitativefindingsstatements
AT lewinsimona qualitativeevidencesynthesisqesforguidelinespaper1usingqualitativeevidencesynthesistoinformguidelinescopeanddevelopqualitativefindingsstatements
AT glentonclaire qualitativeevidencesynthesisqesforguidelinespaper1usingqualitativeevidencesynthesistoinformguidelinescopeanddevelopqualitativefindingsstatements
AT rosenbaumsarah qualitativeevidencesynthesisqesforguidelinespaper1usingqualitativeevidencesynthesistoinformguidelinescopeanddevelopqualitativefindingsstatements
AT barreixmaria qualitativeevidencesynthesisqesforguidelinespaper1usingqualitativeevidencesynthesistoinformguidelinescopeanddevelopqualitativefindingsstatements
AT tuncalpozge qualitativeevidencesynthesisqesforguidelinespaper1usingqualitativeevidencesynthesistoinformguidelinescopeanddevelopqualitativefindingsstatements